Indian Pharmaceuticals
-
{
- All
- News
-
US Turn To Indian Pharmaceuticals Amid Critical Cancer Drug Shortage
- Tuesday June 23, 2026
- Health | Written by Sambhav Kumar
US has sought help from Indian pharmaceutical manufacturers to address a shortage of the cancer drug ifosfamide.
-
www.ndtv.com/health
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
- Wednesday January 28, 2026
- Health | Edited by Shreya Goswami
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
www.ndtv.com/health
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
- Wednesday January 28, 2026
- Health | Edited by Shreya Goswami
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
www.ndtv.com/health
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Nearly Half Of Indian Healthcare, Pharma Firms Plan To Integrate Gen AI Within A Year: EY
- Tuesday January 30, 2024
- Author: NDTV Profit Tech
60% of healthcare and pharma leaders believe generative AI will have a significant impact on the entire value chain.
-
www.ndtvprofit.com
-
Indian Pharma Eyes Pride Of Place, Regulation Achilles Heel
- Friday December 8, 2023
- Author: Press Trust of India
The $32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises.
-
www.ndtvprofit.com
-
Price Controls: Pharma Industry Favours Dialogue With Government, Says Report
- Thursday December 7, 2023
- Author: NDTV Profit Desk
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
-
www.ndtvprofit.com
-
Pharma Exports to US to Remain Unaffected by Import Alerts: India Ratings
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Indian pharmaceutical exports to the US are expected to keep growing despite a spate of import alerts issued by the American drug regulator in 2013, according to a report by India Ratings & Research.
-
www.ndtvprofit.com
-
Moscow Says India May Replace West In Russian Pharmaceuticals Market: Report
- Friday March 18, 2022
- India News | Asian News International
Indian pharmaceutical companies may replace Western manufacturers leaving the Russian market, Russian envoy to India Denis Alipov said on Friday.
-
www.ndtv.com
-
Volume Decline Muted Pharmaceutical Market Growth In November
- Tuesday December 22, 2020
- Edited by: Nikita Prasad
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
www.ndtvprofit.com
-
FDC Drug Ban: When Will The Indian Drug Regulator Start...Well, Regulating?
- Sunday September 23, 2018
- Author: Murali Neelakantan
Regulations haven’t kept pace with the developments in the healthcare sector and the regulator has been lax in doing its duty.
-
www.ndtvprofit.com
-
US Turn To Indian Pharmaceuticals Amid Critical Cancer Drug Shortage
- Tuesday June 23, 2026
- Health | Written by Sambhav Kumar
US has sought help from Indian pharmaceutical manufacturers to address a shortage of the cancer drug ifosfamide.
-
www.ndtv.com/health
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
- Wednesday January 28, 2026
- Health | Edited by Shreya Goswami
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
www.ndtv.com/health
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
- Wednesday January 28, 2026
- Health | Edited by Shreya Goswami
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
www.ndtv.com/health
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Nearly Half Of Indian Healthcare, Pharma Firms Plan To Integrate Gen AI Within A Year: EY
- Tuesday January 30, 2024
- Author: NDTV Profit Tech
60% of healthcare and pharma leaders believe generative AI will have a significant impact on the entire value chain.
-
www.ndtvprofit.com
-
Indian Pharma Eyes Pride Of Place, Regulation Achilles Heel
- Friday December 8, 2023
- Author: Press Trust of India
The $32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises.
-
www.ndtvprofit.com
-
Price Controls: Pharma Industry Favours Dialogue With Government, Says Report
- Thursday December 7, 2023
- Author: NDTV Profit Desk
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
-
www.ndtvprofit.com
-
Pharma Exports to US to Remain Unaffected by Import Alerts: India Ratings
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Indian pharmaceutical exports to the US are expected to keep growing despite a spate of import alerts issued by the American drug regulator in 2013, according to a report by India Ratings & Research.
-
www.ndtvprofit.com
-
Moscow Says India May Replace West In Russian Pharmaceuticals Market: Report
- Friday March 18, 2022
- India News | Asian News International
Indian pharmaceutical companies may replace Western manufacturers leaving the Russian market, Russian envoy to India Denis Alipov said on Friday.
-
www.ndtv.com
-
Volume Decline Muted Pharmaceutical Market Growth In November
- Tuesday December 22, 2020
- Edited by: Nikita Prasad
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
www.ndtvprofit.com
-
FDC Drug Ban: When Will The Indian Drug Regulator Start...Well, Regulating?
- Sunday September 23, 2018
- Author: Murali Neelakantan
Regulations haven’t kept pace with the developments in the healthcare sector and the regulator has been lax in doing its duty.
-
www.ndtvprofit.com